Cancer cells’ ability to adapt could yield new treatment approaches, NYU-led study finds

Microplastics are discovered in prostate tumors, NYU researchers present at ASCO GU

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, according to a study led by NYU Langone Health, its Perlmutter Cancer Center, and its Center for the Investigation of Environmental Hazards.

February 27, 2026

Vol.52 No.08

Conversation with The Cancer Letter

On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center

Last summer, Anirban Maitra, a pathologist specializing in pancreatic cancer, joined the NYU Langone Health Laura and Isaac Perlmutter Cancer Center to co-lead its Gastrointestinal Cancer Center.

Oral microbes linked to increased risk of pancreatic cancer

Twenty-seven species of bacteria and fungi, among the hundreds that live in people’s mouths, have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, according to a study led by NYU Langone Health and its Perlmutter Cancer Center.

September 19, 2025

Vol.51 No.34

In Brief

Anirban Maitra, Manuel Hidalgo, join NYU Langone new GI cancer center as co-directors

Anirban Maitra and Manuel Hidalgo were named co-directors of a new Gastrointestinal Cancer Center at NYU Langone Health’s Perlmutter Cancer Center.

September 12, 2025

Vol.51 No.33

In Brief

With $60M in gifts, NYU Langone to create Mignone Women’s Health Collaborative and treat women at every life stage

NYU Langone announced on May 21 the creation of the Mignone Women’s Health Collaborative, building upon the system’s health care services for women and deepening coordination between specialists who work together to treat women at every stage of life.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

A five-year study on subjects who had only the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

March 07, 2025

Vol.51 No.09

Cancer cells’ ability to adapt could yield new treatment approaches, NYU-led study finds

YOU MAY BE INTERESTED IN

Microplastics are discovered in prostate tumors, NYU researchers present at ASCO GU

On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center

Oral microbes linked to increased risk of pancreatic cancer

Anirban Maitra, Manuel Hidalgo, join NYU Langone new GI cancer center as co-directors

With $60M in gifts, NYU Langone to create Mignone Women’s Health Collaborative and treat women at every life stage

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

Renew today!

Subscriber content

Never miss an issue!

Login